Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laparoscopic TAP Block with Liposomal Bupivacaine in Hysterectomy
NCT05763667Phase 3Completed
- Sponsor
- Tufts Medical Center
- Start
- Jan 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of liposomal bupivacaine in postoperative pain (3 arms), sponsored by Tufts Medical Center. Primary endpoint: Reduced opiate use in both TAP block arms at 7 days. Started Jan 2024; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05763667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05763667.